FCM
VERA icon

Frontier Capital Management’s Vera Therapeutics VERA Stock Holding History

Frontier Capital Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.6M Buy
1,295,405
+743,912
+135% +$27.7M 0.52% 55
2026
Q1 		$22.2M Buy
551,493
+180,342
+49% +$7.77M 0.23% 159
2025
Q4 		$18.8M Buy
+371,151
New +$13.2M 0.2% 175

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Frontier Capital Management's VERA Position: Q2 2026 in Review

Frontier Capital Management increased its Vera Therapeutics (VERA) stake by 135% in Q2 2026, buying an estimated $27.7M and bringing the position to 1,295,405 shares worth $55.6M. The position accounts for 0.52% of the portfolio, ranked #55.

Frontier Capital Management first reported a position in VERA in Q4 2025 and has held it in 3 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Frontier Capital Management held 1,295,405 shares of Vera Therapeutics worth $55.6M as of Q2 2026.
  • Frontier Capital Management bought 743,912 Vera Therapeutics shares in Q2 2026, an estimated $27.7M.
  • Vera Therapeutics made up 0.52% of Frontier Capital Management's portfolio in Q2 2026, its #55 holding.
  • Frontier Capital Management first reported a position in Vera Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Frontier Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.